Effect of Fingolimod in Multiple Sclerosis
Phase 2
Recruiting
- Conditions
- Multiple Sclerosis.Multiple sclerosis
- Registration Number
- IRCT20180204038608N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Age should be between 18 to 55 years old
The type of disease should be Relapsing Remitting
There should not be any evidence of relapse in the past 30 days
EDSS score should be between 0 to 5.5
Exclusion Criteria
Have Relapse or use of Corticosteroids in the past 30 days
Have an active infection
Have a history of diabetes
Have cardiac problems and use of anti arrhythmic drugs
Taking drugs such as Azathioprine and Methotrexate
WBCs less than 3500 and lymphocyte count less than 800
Taking heart beat reducer drugs
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disease disability score,Annualized Relapse rate. Timepoint: Determining of Disease disability score at the beginning of study and after one year,Relapse rate during the past year and one year after starting Fingolimod. Method of measurement: Expanded Disability Status Scale score ,Annualized Relapse rate with negative bi nominal regression.
- Secondary Outcome Measures
Name Time Method